| Product Name | MF | CAS | Details |
|---|
| (R)-1-(2-chloroacetyl)pyrrolidine-2-carboxaMide | C7H11ClN2O2 | 1211679-98-9 | Details |
| vildagliptin Impurity Q | C7H10Cl2N2O2 | 1803168-08-2 | Details |
| Vildagliptin Impurity 42 | C5H9ClN2 | 65732-69-6 | Details |
| Vildagliptin Impurity 53 | C7H10N2O | 700376-84-7 | Details |
| 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]- | C30H26N8O3 | 2469626-53-5 | Details |
| Linagliptin Impurity 28 | C22H23N7O3 | 2074688-84-7 | Details |
| Linagliptin impurity 16 | C26H29N9O3 | 1955514-80-3 | Details |
| Linagliptin Impurity 33 | C38H42N10O4 | 2443735-53-1 | Details |
| INDEX NAME NOT YET ASSIGNED | C21H24N8O2 | 2748491-45-2 | Details |
| Linagliptin Impurity S | C30H36N8O4 | 668273-74-3 | Details |
| 2,4,6-Tritertbutylphenol (25 mg) (2,4,6-Tri-tert-butylphenol) | C18H30O | 732-26-3 | Details |
| 2,6-Dichlorophenylacetic Acid | C8H6Cl2O2 | 6575-24-2 | Details |
| 2-Acetylpyridine (1 g) | C7H7NO | 1122-62-9 | Details |
| 2,3-Dimethyl-2,3-butanediamine Dihydrochloride (25 mg) (2,3-dimethylbutane-2,3-diamine, hydrochloride) | C6H18Cl2N2 | 75804-28-3 | Details |
| 2,3-Butanedithiol (3 x 1 g) | C4H10S2 | 4532-64-3 | Details |
| 2'-Fucosyllactose (200 mg) | C18H32O15 | 41263-94-9 | Details |
| 12-Hydroxystearic Acid (200 mg) | C18H36O3 | 106-14-9 | Details |
| 1-Ethoxy-2-Methylpropane (3 x 0.2 mL) | C6H14O | 627-02-1 | Details |
| 1-Cyclopentyl-4-nitrosopiperazine (CPNP) Solution (1 mL (1 mg/mL)) (1-Cyclopentyl-4-nitrosopiperazine) | C9H17N3O | 61379-66-6 | Details |
| 1-Benzhydryl-4-nitrosopiperazine Solution (1 mL (1 mg/mL)) (1-benzhydryl-4-nitrosopiperazine) | C17H19N3O | 1698-25-5 | Details |
| 1-(2-Methoxyphenyl)-4-nitrosopiperazine Solution (1 mL (1 mg/mL)) (1-(2-Methoxyphenyl)-4-nitrosopiperazine) | C11H15N3O2 | 2219339-64-5 | Details |
| 1,6-anhydro-D-glucose (50 mg) | C6H10O5 | 498-07-7 | Details |
| (+)-Catechin (25 mg) | C15H14O6 | 154-23-4 | Details |
| (-)-Epicatechin (50 mg) | C15H14O6 | 490-46-0 | Details |
| (1S,2R)-Eliglustat Diastereomer (25 mg) (N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide) | C23H36N2O4 | 1092472-65-5 | Details |
| (E)-Thiothixene (100 mg) | C23H29N3O2S2 | 3313-27-7 | Details |
| 1,2-Dinitroglycerin (2 ampules x 1 mL) | C3H6N2O7 | 621-65-8 | Details |
| 1,3-Dimethyl-6-nitroindazole (25 mg) (1,3-dimethyl-6-nitro-1H-indazole) | C9H9N3O2 | 1354224-47-7 | Details |
| 1,3-Dinitroglycerin (2 ampules x 1 mL) | C3H6N2O7 | 623-87-0 | Details |
| 1,3-Propanediol (1 mL) | C3H8O2 | 504-63-2 | Details |
| (R)-1-Boc-3-Aminopiperidine | C10H20N2O2 | 625471-18-3 | Details |
| INDEX NAME NOT YET ASSIGNED | C26H32N8O4 | 2748381-67-9 | Details |
| 6'-DesMethyl-6'-Methylhydroxy Etoricoxib | C18H15ClN2O3S | 349536-41-0 | Details |
| tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate | C20H28N4O2 | 2514949-81-4 | Details |
| 4-Hydroxyindole (25 mg) (1H-Indol-4-ol) | C8H7NO | 2380-94-1 | Details |
| 4-Hydroxyisoleucine (35 mg) | C6H13NO3 | 781658-23-9 | Details |
| 4-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4'-Methylacetophenone)) | C9H10O | 122-00-9 | Details |
| 4-Nitroso-1-(4-fluorobenzoyl)piperazine Solution (1 mL (1 mg/mL)) ((4-fluorophenyl)(4-nitrosopiperazin-1-yl)methanone) | 2892260-28-3 | Details |
| 4-Nitrosopiperazine-1-ethanol Solution (1 mL (1 mg/mL)) (2-(4-Nitrosopiperazin-1-yl)ethan-1-ol) | C6H13N3O2 | 48121-20-6 | Details |
| 4-Phenylbutyl(benzyl)amine hydrochloride (25 mg) (N-benzyl-4-phenylbutan-1-amine, hydrochloride) | C25H37NO4 | 144391-74-2 | Details |
| 3-Acetyl-11-Keto-Beta-Boswellic Acid (20 mg) | C32H48O5 | 67416-61-9 | Details |
| 3-Amino-2,4,6-triiodobenzoic Acid (50 mg) | C7H4I3NO2 | 3119-15-1 | Details |
| 6,6'-Dinicotinic Acid (50 mg) | C12H8N2O4 | 1802-30-8 | Details |
| 6-Ethylpyrimidine-2,4-diamine (25 mg) (6-Ethylpyrimidine-2,4-diamine) | C6H10N4 | 514854-12-7 | Details |
| 6-Hydroxynicotinic Acid (50 mg) | C6H5NO3 | 5006-66-6 | Details |
| 6-Methyl-4-phenylchromanol (25 mg) (6-Methyl-4-phenylchroman-2-ol) | C16H16O2 | 209747-04-6 | Details |
| 6-Methyl-4-phenylchromanone (25 mg) (6-Methyl-4-phenylchroman-2-one) | C16H14O2 | 40546-94-9 | Details |
| 6-Methylnicotinic Acid (50 mg) | C7H7NO2 | 3222-47-7 | Details |
| 6-O-Methylerythromycin A 9-(O-methyloxime) (25 mg) | C39H72N2O13 | 107216-09-1 | Details |
| 8-Bromotheophylline (400 mg) | C7H7BrN4O2 | 10381-75-6 | Details |
| 7-Chloromethyl Drospirenone (10 mg) | C24H31ClO3 | 932388-90-4 | Details |
| 7-Chloromethyl 17-Epidrospirenone (25 mg) | C24H31ClO3 | 932388-89-1 | Details |
| 5-Me Bz dC Beta-Cyanoethyl Phosphoramidite (500 mg) (5-Methyl-5'-O-Dimethoxytrityl-N4-benzoyl-2'-deoxycytidine-3'-O-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite) | C47H54N5O8P | 105931-57-5 | Details |
| 5-O-Methylvisammioside (25 mg) | C22H28O10 | 84272-85-5 | Details |
| 5-Phenylhydantoin (100 mg) | C9H8N2O2 | 89-24-7 | Details |
| N-Phthalimide-linagliptin | C33H30N8O4 | 886588-63-2 | Details |
| Linagliptin impurity KH-2 | C20H18BrN5O4 | 2279114-31-5 | Details |
| Linagliptin Impurity 29 | C58H58N16O6 | 2074688-82-5 | Details |
| Acetamide, N-(2-acetylphenyl)-2,2-dichloro- | C10H9Cl2NO2 | 6140-12-1 | Details |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C15H20N2O6 | 144978-05-2 | Details |
| Olmesartan Medoxomil Impurity G | C43H38N6O2 | 761404-82-4 | Details |
| Olmesartan Impurity 9 | C10H14N2O2 | 849206-42-4 | Details |
| Olmesartan Medoxomil Impurity 17 | C53H54N12O8 | 1418133-31-9 | Details |
| 1H-Imidazole-4,5-dicarboxylic acid, 2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- | C41H34N6O4 | 1350442-05-5 | Details |
| Olmesartan Impurity G | C33H24Br2N4 | 358685-13-9 | Details |
| Olmesartan Medoxomil Impurity O | C45H44N6O3 | 189400-21-3 | Details |
| (2S)-1-(2-chloroacetyl)-N,N-dimethylpyrrolidine-2-carboxamide | C9H15ClN2O2 | 2381862-94-6 | Details |
| Vildagliptin Related Compound A | C17H25N3O | 741657-02-3 | Details |
| Vildagliptin Carboxylic Acid Methyl Ester | C18H28N2O4 | 948574-56-9 | Details |
| (S)-1-N-CBZ-2-CYANO-PYRROLIDINE | C13H14N2O2 | 63808-36-6 | Details |
| Vildagliptin Impurity 13 | C6H11NO2 | 2577-48-2 | Details |
| (2S)-1-(2,2,2-trifluoroacetyl)pyrrolidine-2-carbonitrile; 2-Pyrrolidinecarbonitrile, 1-(trifluoroacetyl)-, (S)- (9CI) | C7H7F3N2O | 151258-26-3 | Details |
| Vildagliptin Impurity 57 | C7H12ClN3O | 913980-23-1 | Details |
| 2-Monobromo Aripiprazole Hydrochloride (25 mg) (7-(4-(4-(2-bromophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one, hydrochloride) | C23H29BrClN3O2 | 2748462-55-5 | Details |
| XYLOTAXOL, 7-(RG) | C52H59NO18 | 90332-66-4 | Details |
| N,S-Carboxymethyl Cysteine | C7H11NO6S | 907565-13-3 | Details |
| 4-Thiomorpholineacetic acid, 3-carboxy-5-oxo-, (3R)- | C7H9NO5S | 1601460-92-7 | Details |
| R(+)-TRANS[ETHOXY CARBONYLMETHYL]-1-PHENYLETHYLAMINE | C12H17NO2 | 66512-37-6 | Details |
| 3-(1-PHENYL-ETHYL)-3H-IMIDAZOLE-4-CARBOXYLIC ACID | C12H12N2O2 | 3157-27-5 | Details |
| 2-Propenoic acid, 2-[formyl[(1R)-1-phenylethyl]amino]-3-hydroxy-, ethyl ester | C14H17NO4 | 1357291-60-1 | Details |
| Etomidate Impurity 20 | C14H16N2O2S | 112421-33-7 | Details |
| 1H-Imidazole-4-carboxylicacid, 2,3-dihydro-3-(1-phenylethyl)-2-thioxo-, methyl ester | Details |
| methyl (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylate | C13H14N2O2 | 61045-91-8 | Details |
| 2E, 4E-Hexadienoic Acid Isobutylamide (25 mg) | C10H17NO | 65937-49-7 | Details |
| 23-EPI-26-Deoxyactein (20 mg) | C37H56O10 | 501938-01-8 | Details |
| 2-Oxo R-Clopidogrel (10 mg) (methyl (2R)-2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) | C16H16ClNO3S | 1360923-54-1 | Details |
| 2-Mononitroglycerin (2 ampules x 1 mL) | C3H7NO5 | 620-12-2 | Details |
| 5-Amino-2,4,6-triiodo-N-methylisophthalamic Acid (50 mg) | C9H7I3N2O3 | 2280-89-9 | Details |
| 3-Amino-4-tolylsulfonamide (25 mg) (3-amino-4-methylbenzenesulfonamide) | C7H10N2O2S | 6274-28-8 | Details |
| 3-Benzyl-4-Heptanone (5 x 0.5 mL) | C14H20O | 7492-37-7 | Details |
| 3-Chloropropiophenone (25 mg) (1-Phenyl-3-chloro-1-propanone) | C9H9ClO | 936-59-4 | Details |
| 4-Epianhydrotetracycline Hydrochloride (50 mg) | C22H23ClN2O7 | 4465-65-0 | Details |
| 5'-Cytidylic Acid (500 mg) | C9H14N3O8P | 63-37-6 | Details |
| 4-Hydroxy Duloxetine Acetate (25 mg) ((S)-4-(3-(methylamino)-1-(thiophen-2-yl)propoxy)naphthalen-1-ol, acetate) | 2705426-23-7 | Details |
| 2-Oxo Clopidogrel (Mixture of Diastereomers) (10 mg) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate) | C16H16ClNO3S | 109904-27-0 | Details |
| Product Total： Product Page： | ||||
| 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 | ||||